Opprtna Therapeutics is pioneering the use of precision aptamers to develop innovative treatments for neurodegenerative diseases and cancer. Their approach focuses on harnessing the unique properties of aptamers—short, single-stranded DNA or RNA molecules that can bind to specific proteins. By targeting disease-related proteins that interact with RNA and DNA, Opprtna aims to create a novel drug modality that not only halts the progression of these diseases but also ensures targeted and safe delivery of therapies. This method represents a significant advancement in drug development, particularly for patients who have previously been considered untreatable.

The company emphasizes the potential applications of their technology, which have shown initial success in addressing select targets within oncology and neurodegenerative indications. By leveraging insights from disease biology and drawing inspiration from natural processes, Opprtna Therapeutics is committed to transforming the treatment landscape. Their mission is to empower patients with safer and more effective therapies, ultimately providing hope for those facing significant health challenges.

United States

We are a promising aptamer-based platform company ready to make a profound impact across multiple therapeutic areas. We are looking for partners who share that conviction. Contact us to learn more.

Opprtna Therapeutics

Company Details